Amblyopia Market Size, Share, Industry & Opportunities 2030
Amblyopia Market Size, Share, Industry & Opportunities 2030
Segments - Global Amblyopia Market By Treatments (Atropine Drops, Eye Patches, Glasses, Video Game, and Others), By End-users (Ophthalmic Clinics, Hospitals & Pharmacies and Others), By Diagnosis (Visual Acuity Tests, Photo Screening, Brückner Test, and Others), By Types (Strabismus Amblyopia, Refractive Amblyopia, Deprivation Amblyopia, Reverse Amblyopia, and Others) and By Regions (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 – 2027
Upcoming
| Report ID :HC-96
| 4.5 Rating
| 62 Reviews
| 159 Pages
| Format :
Report Description
Market Outlook:
The global amblyopia market was valued at USD 4,608.2 Million in 2019 and is projected to reach US$ 6,203.6 Million by 2027, expanding at a CAGR of 4.0% during the forecast period. Amblyopia occurs in early childhood when the brain favors only one of the eye due to improper stimulation between the brain and an eye nerve pathway.
Market Dynamics
The market is driven by factors such as increasing cases of ophthalmological disorders including refractive errors and cataracts across the globe. Moreover, favorable government funding for ophthalmology research is boosting market growth in developing countries such as India, Mexico, and China. Increasing demand for glasses and eye patches at economic costs is fueling growth of the global amblyopia market. Rising treatments pertaining to amblyopia has now extended beyond patching for youngsters and adults to help patients of any ages to get rid of diseases in the present scenario. Thus, consumers are now encouraged to avail for amblyopia treatments around the world.
Modern techniques including the introduction of electronic eyeglasses and lenses are considered as efficient medications of the treatment of amblyopia. These types of modern techniques increase consumer awareness and encourage them to adopt eyeglass, which can be used as part of fashion in correspondence with treatment.
Lack of awareness pertaining to amblyopia treatment and lack of strict government regulation regarding new treatment methods in developing regions challenges the growth of the amblyopia market. Lack of technological advancement and availability of resources restricts the growth of the market globally.
Segmental Outlook
On the basis of treatment, the Global Amblyopia Market has been segmented into eye patches, atropine drops, glasses, video game, and others. The video game treatment segment is anticipated to expand at a CAGR of around 4.1% during the forecast period due to increasing awareness and technological advancements pertaining to the treatment. The eye patches segment is estimated to hold 35.9% share of the market in 2019, as it is a highly preferred treatment for amblyopia in hospitals and various eye care centers.
Based on end-users, the market has been divided into hospitals & pharmacies, ophthalmic clinics, and others. The hospitals & pharmacies segment is projected to hold a dominant share of the market during the forecast period due to easy availability of treatment facilities. Additionally, near ability and awareness about hospitals and pharmacies among end-users support significant share in the market, globally.
The ophthalmic clinics segment is expected to grow at a substantial pace owing to the growing awareness regarding these centers among consumers. Moreover, increasing company focus on opening of new ophthalmic clinics is propelling the growth in the global amblyopia market. New and emerging players are focusing on this segment to withstand the competition in the global amblyopia market.
In terms of diagnosis, the global amblyopia market has been segregated into visual acuity tests, photo screening, Brücknertest, and others. The visual acuity tests segment account for a major share in the global amblyopia market, as it is a basic and mandatory test required before the amblyopia treatment. Increasing research & development and continuous improvements in the Brückner test is fueling the growth of this segment in the global amblyopia market.
Based on types, the market has been classified as strabismus amblyopia, refractive amblyopia, deprivation amblyopia, reverse amblyopia, and others. The strabismus amblyopia segment holds a key share of the amblyopia market. Moreover, this segment is estimated to expand at a significant CAGR during the forecast period due to increasing number of patients with strabismus amblyopia.
Definitions
By Types
Deprivation Amblyopia: This is common type of amblyopia, which is developed when the visual axis is obstructed. In some patients this is caused by something that obstructs being focused on a baby's eye. Eyelid ptosis, cataracts, corneal opacities, vitreous hemorrhage and others are various causes of stimulus deprivation.
Refractive Amblyopia: Unequal refractive error in the eyes causes amblyopia. For example, one eye can have substantial uncorrected farsightedness or nearsightedness, while the other eye does not. In such cases the human relies on the eyes with fewer errors, causing amblyopia in that eye from disuse.
Reverse Amblyopia: This kind of amblyopia adversely affects binocularity, contrast sensitivity, grating acuity visual acuity, and central versus eccentric fixation.
Strabismus Amblyopia: Strabismus is a predominant cause of amblyopia. The brain lacks the visual feedback from the misaligned eye to prevent double vision caused by incorrectly aligned eyes, resulting in amblyopia in that eye. This type of amblyopia is called strabismus amblyopia. Strabismus amblyopia results from suppression of the deviating eye. Constant strabismus leads to more severe amblyopia than intermittent strabismus.
Regional Outlook
In terms of regions, the global amblyopia market has been fragmented into Europe, North America, Latin America, Asia Pacific and Middle East & Africa. North America is a promising region for the market. The region constituted 37.6% share of the market in 2019. The market in the region is anticipated to expand at a CAGR of ~3.1% during the forecast period.
Significant market share of North America is attributed to the presence of advanced technologies in the medical industry. Moreover, easy availability of recourses supports the growth of key players and new entrance in the market in this region. Increasing number of amblyopia cases in Europe is driving the growth of the market in the region. High purchasing power among consumers in the region positively influences the growth of the market. The market in Asia Pacific region is expected to grow at a significant rate during the forecast period due to increasing availability of amblyopia treatment technologies in the region. Moreover, increasing penetration of new companies, through mergers and acquisitions, fuels the market in the region.
Key Benefits for Industry Participants & Stakeholders
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the global amblyopia market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the global amblyopia market
Segments
By Treatments
- Eye Patches
- Glasses
- Video Game
- Atropine Drops
- Others
By End-users
- Hospitals & Pharmacies
- Ophthalmic Clinics
- Others
By Diagnosis
- Visual Acuity Tests
- Photo Screening
- Brückner Test
- Others
By Types
- Strabismus Amblyopia
- Refractive Amblyopia
- Deprivation Amblyopia
- Reverse Amblyopia
- Others
By Regions
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Russia
- Rest of the Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- South East Asia (SEA)
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Rest of MEA
Key Market Players Profiled in the Report
- Amblyotech
- Good-Lite Company
- Vivid Vision, Inc.
- CooperVision Inc.
- Johnson & Johnson
- Novartis AG
- Carl Zeiss AG
- HOYA Corporation
- Fresnel Prism and Lens Co.
- Hilco Vision
- Others
Competitive Landscape
- Key players in the market include Amblyotech, Good-Lite Co., Vivid Vision, Cooper Vision, Johnson & Johnson, Novartis AG, Carl Zeiss, HOYA Corporation, Fresnel Prism and Lens, and Hilco Vision.
- These companies are considered as key players in global amblyopia market based on their revenue, research development (R&D) activities, regional presence, and supply chain management system.
- Key players in the market are principally engaged in acquiring regional players to increase their sales and footprint across the globe. For instance, in 2019, CooperVision, Inc., acquired Blanchard Contact Lenses, Inc., which helped the company to expand its presence in the specialty segment.
- In the year 2019, Novartis AG acquired Takeda eye drug for approximately US$ 5.3 Bn, which helped the company to expand its product portfolio.
- Companies can withstand competition in the amblyopia market by adopting latest technologies, increasing consumer awareness, and partnerships with hospitals and eye care centers.
Video Summary for Amblyopia Market
Frequently Asked Questions
Additional company profiles can be provided on request.
Yes, the report covers treatment segment analysis.
According to this Growth Market Reports report, the market from amblyopia is likely to register a CAGR of 4.0% during forecast period between 2020 and 2027, with an anticipated valuation of US$ 6,203.6 million by the end of the 2027.
Market size (in US$ Million) and company market share (in % for base year 2019), other data such as COVID-19 impact on amblyopia market and regulatory outlook is available in the final report.
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
Changing lifestyles and preferences, health awareness, medical industry advancement, introduction of new treatment methods, and increase in R&D expenditure by manufacturers for developing new amblyopia treatment equipment is expected to drive the market growth during forecast period.
Hospital & pharmacies and ophthalmic clinics are the key end-users that are driving the amblyopia market.
The market is expected to witness decline of over 2.3% between 2019 and due to the adverse impact of COVID 19 pandemic on supply chain of medical industry.
The base year considered for the global amblyopia market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017, 2018 are the historic years, 2019 is the base year and the forecast is provided from 2020 to 2027.
Major manufacturers include, Amblyotech, Good-Lite Co., VividVision, CooperVision Inc., and Johnson & Johnson
Table Of Content
Chapter 1 Executive SummaryChapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Amblyopia Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Amblyopia Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Amblyopia Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Amblyopia Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Amblyopia Market Size & Forecast, 2017-2027
4.5.1 Amblyopia Market Size and Y-o-Y Growth
4.5.2 Amblyopia Market Absolute $ Opportunity
4.6 Global Amblyopia Market: Regulatory Outlook
Chapter 5 Global Amblyopia Market Analysis and Forecast By Treatment
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities By Treatment
5.1.2 Basis Point Share (BPS) Analysis By Treatment
5.1.3 Absolute $ Opportunity Assessment By Treatment
5.2 Amblyopia Market Size Forecast By Treatment
5.2.1 Eye Patches
5.2.2 Glasses
5.2.3 Video Game
5.2.4 Atropine Drops
5.2.5 Others
5.3 Market Attractiveness Analysis By Treatment
Chapter 6 Global Amblyopia Market Analysis and Forecast By End-user
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities By End-user
6.1.2 Basis Point Share (BPS) Analysis By End-user
6.1.3 Absolute $ Opportunity Assessment By End-user
6.2 Amblyopia Market Size Forecast By End-user
6.2.1 Hospitals & Pharmacies
6.2.2 Ophthalmic Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis By End-user
Chapter 7 Global Amblyopia Market Analysis and Forecast By Diagnosis
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities By Diagnosis
7.1.2 Basis Point Share (BPS) Analysis By Diagnosis
7.1.3 Absolute $ Opportunity Assessment By Diagnosis
7.2 Amblyopia Market Size Forecast By Diagnosis
7.2.1 Visual Acuity Tests
7.2.2 Photo Screening
7.2.3 Brückner Test
7.2.4 Others
7.3 Market Attractiveness Analysis By Diagnosis
Chapter 8 Global Amblyopia Market Analysis and Forecast By Type
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities By Type
8.1.2 Basis Point Share (BPS) Analysis By Type
8.1.3 Absolute $ Opportunity Assessment By Type
8.2 Amblyopia Market Size Forecast By Type
8.2.1 Strabismus Amblyopia
8.2.2 Refractive Amblyopia
8.2.3 Deprivation Amblyopia
8.2.4 Reverse Amblyopia
8.2.5 Others
8.3 Market Attractiveness Analysis By Type
Chapter 9 Global Amblyopia Market Analysis and Forecast by Region
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Region
9.1.2 Basis Point Share (BPS) Analysis by Region
9.1.3 Absolute $ Opportunity Assessment by Region
9.2 Amblyopia Market Size Forecast by Region
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa (MEA)
9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
10.1 Introduction
10.2 Current & Future Impact Analysis
10.3 Economic Impact Analysis
10.4 Government Policies
10.5 Investment Scenario
Chapter 11 North America Amblyopia Analysis and Forecast
11.1 Introduction
11.2 North America Amblyopia Market Size Forecast by Country
11.2.1 U.S.
11.2.2 Canada
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 North America Amblyopia Market Size Forecast By Treatment
11.6.1 Eye Patches
11.6.2 Glasses
11.6.3 Video Game
11.6.4 Atropine Drops
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis By Treatment
11.8 Absolute $ Opportunity Assessment By Treatment
11.9 Market Attractiveness Analysis By Treatment
11.10 North America Amblyopia Market Size Forecast By End-user
11.10.1 Hospitals & Pharmacies
11.10.2 Ophthalmic Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis By End-user
11.12 Absolute $ Opportunity Assessment By End-user
11.13 Market Attractiveness Analysis By End-user
11.14 North America Amblyopia Market Size Forecast By Diagnosis
11.14.1 Visual Acuity Tests
11.14.2 Photo Screening
11.14.3 Brückner Test
11.14.4 Others
11.15 Basis Point Share (BPS) Analysis By Diagnosis
11.16 Absolute $ Opportunity Assessment By Diagnosis
11.17 Market Attractiveness Analysis By Diagnosis
11.18 North America Amblyopia Market Size Forecast By Type
11.18.1 Strabismus Amblyopia
11.18.2 Refractive Amblyopia
11.18.3 Deprivation Amblyopia
11.18.4 Reverse Amblyopia
11.18.5 Others
11.19 Basis Point Share (BPS) Analysis By Type
11.20 Absolute $ Opportunity Assessment By Type
11.21 Market Attractiveness Analysis By Type
Chapter 12 Europe Amblyopia Analysis and Forecast
12.1 Introduction
12.2 Europe Amblyopia Market Size Forecast by Country
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 U.K.
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Europe Amblyopia Market Size Forecast By Treatment
12.6.1 Eye Patches
12.6.2 Glasses
12.6.3 Video Game
12.6.4 Atropine Drops
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis By Treatment
12.8 Absolute $ Opportunity Assessment By Treatment
12.9 Market Attractiveness Analysis By Treatment
12.10 Europe Amblyopia Market Size Forecast By End-user
12.10.1 Hospitals & Pharmacies
12.10.2 Ophthalmic Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis By End-user
12.12 Absolute $ Opportunity Assessment By End-user
12.13 Market Attractiveness Analysis By End-user
12.14 Europe Amblyopia Market Size Forecast By Diagnosis
12.14.1 Visual Acuity Tests
12.14.2 Photo Screening
12.14.3 Brückner Test
12.14.4 Others
12.15 Basis Point Share (BPS) Analysis By Diagnosis
12.16 Absolute $ Opportunity Assessment By Diagnosis
12.17 Market Attractiveness Analysis By Diagnosis
12.18 Europe Amblyopia Market Size Forecast By Type
12.18.1 Strabismus Amblyopia
12.18.2 Refractive Amblyopia
12.18.3 Deprivation Amblyopia
12.18.4 Reverse Amblyopia
12.18.5 Others
12.19 Basis Point Share (BPS) Analysis By Type
12.20 Absolute $ Opportunity Assessment By Type
12.21 Market Attractiveness Analysis By Type
Chapter 13 Asia Pacific Amblyopia Analysis and Forecast
13.1 Introduction
13.2 Asia Pacific Amblyopia Market Size Forecast by Country
13.2.1 China
13.2.2 Japan
13.2.3 South Korea
13.2.4 India
13.2.5 Australia
13.2.6 South East Asia (SEA)
13.2.7 Rest of Asia Pacific (APAC)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Asia Pacific Amblyopia Market Size Forecast By Treatment
13.6.1 Eye Patches
13.6.2 Glasses
13.6.3 Video Game
13.6.4 Atropine Drops
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis By Treatment
13.8 Absolute $ Opportunity Assessment By Treatment
13.9 Market Attractiveness Analysis By Treatment
13.10 Asia Pacific Amblyopia Market Size Forecast By End-user
13.10.1 Hospitals & Pharmacies
13.10.2 Ophthalmic Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis By End-user
13.12 Absolute $ Opportunity Assessment By End-user
13.13 Market Attractiveness Analysis By End-user
13.14 Asia Pacific Amblyopia Market Size Forecast By Diagnosis
13.14.1 Visual Acuity Tests
13.14.2 Photo Screening
13.14.3 Brückner Test
13.14.4 Others
13.15 Basis Point Share (BPS) Analysis By Diagnosis
13.16 Absolute $ Opportunity Assessment By Diagnosis
13.17 Market Attractiveness Analysis By Diagnosis
13.18 Asia Pacific Amblyopia Market Size Forecast By Type
13.18.1 Strabismus Amblyopia
13.18.2 Refractive Amblyopia
13.18.3 Deprivation Amblyopia
13.18.4 Reverse Amblyopia
13.18.5 Others
13.19 Basis Point Share (BPS) Analysis By Type
13.20 Absolute $ Opportunity Assessment By Type
13.21 Market Attractiveness Analysis By Type
Chapter 14 Latin America Amblyopia Analysis and Forecast
14.1 Introduction
14.2 Latin America Amblyopia Market Size Forecast by Country
14.2.1 Brazil
14.2.2 Mexico
14.2.3 Rest of Latin America (LATAM)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Latin America Amblyopia Market Size Forecast By Treatment
14.6.1 Eye Patches
14.6.2 Glasses
14.6.3 Video Game
14.6.4 Atropine Drops
14.6.5 Others
14.7 Basis Point Share (BPS) Analysis By Treatment
14.8 Absolute $ Opportunity Assessment By Treatment
14.9 Market Attractiveness Analysis By Treatment
14.10 Latin America Amblyopia Market Size Forecast By End-user
14.10.1 Hospitals & Pharmacies
14.10.2 Ophthalmic Clinics
14.10.3 Others
14.11 Basis Point Share (BPS) Analysis By End-user
14.12 Absolute $ Opportunity Assessment By End-user
14.13 Market Attractiveness Analysis By End-user
14.14 Latin America Amblyopia Market Size Forecast By Diagnosis
14.14.1 Visual Acuity Tests
14.14.2 Photo Screening
14.14.3 Brückner Test
14.14.4 Others
14.15 Basis Point Share (BPS) Analysis By Diagnosis
14.16 Absolute $ Opportunity Assessment By Diagnosis
14.17 Market Attractiveness Analysis By Diagnosis
14.18 Latin America Amblyopia Market Size Forecast By Type
14.18.1 Strabismus Amblyopia
14.18.2 Refractive Amblyopia
14.18.3 Deprivation Amblyopia
14.18.4 Reverse Amblyopia
14.18.5 Others
14.19 Basis Point Share (BPS) Analysis By Type
14.20 Absolute $ Opportunity Assessment By Type
14.21 Market Attractiveness Analysis By Type
Chapter 15 Middle East & Africa (MEA) Amblyopia Analysis and Forecast
15.1 Introduction
15.2 Middle East & Africa (MEA) Amblyopia Market Size Forecast by Country
15.2.1 Saudi Arabia
15.2.2 South Africa
15.2.3 UAE
15.2.4 Rest of Middle East & Africa (MEA)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Middle East & Africa (MEA) Amblyopia Market Size Forecast By Treatment
15.6.1 Eye Patches
15.6.2 Glasses
15.6.3 Video Game
15.6.4 Atropine Drops
15.6.5 Others
15.7 Basis Point Share (BPS) Analysis By Treatment
15.8 Absolute $ Opportunity Assessment By Treatment
15.9 Market Attractiveness Analysis By Treatment
15.10 Middle East & Africa (MEA) Amblyopia Market Size Forecast By End-user
15.10.1 Hospitals & Pharmacies
15.10.2 Ophthalmic Clinics
15.10.3 Others
15.11 Basis Point Share (BPS) Analysis By End-user
15.12 Absolute $ Opportunity Assessment By End-user
15.13 Market Attractiveness Analysis By End-user
15.14 Middle East & Africa (MEA) Amblyopia Market Size Forecast By Diagnosis
15.14.1 Visual Acuity Tests
15.14.2 Photo Screening
15.14.3 Brückner Test
15.14.4 Others
15.15 Basis Point Share (BPS) Analysis By Diagnosis
15.16 Absolute $ Opportunity Assessment By Diagnosis
15.17 Market Attractiveness Analysis By Diagnosis
15.18 Middle East & Africa (MEA) Amblyopia Market Size Forecast By Type
15.18.1 Strabismus Amblyopia
15.18.2 Refractive Amblyopia
15.18.3 Deprivation Amblyopia
15.18.4 Reverse Amblyopia
15.18.5 Others
15.19 Basis Point Share (BPS) Analysis By Type
15.20 Absolute $ Opportunity Assessment By Type
15.21 Market Attractiveness Analysis By Type
Chapter 16 Competition Landscape
16.1 Amblyopia Market: Competitive Dashboard
16.2 Global Amblyopia Market: Market Share Analysis, 2019
16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
16.3.1 Amblyotech
16.3.2 Novartis AG
16.3.3 Good-Lite Co.
16.3.4 VividVision Inc.
16.3.5 CooperVision Inc.
16.3.6 Johnson & Johnson
16.3.7 Novartis AG
16.3.8 Carl Zeiss AG
16.3.9 HOYA Corporation
16.3.10 Fresnel Prism and Lens Co.
16.3.11 Hilco Vision
Methodology
Related Reports
Some other reports from this category!
Our Clients
